IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to HER2-positive Breast Cancer
Related studies linked through entity extraction aliases.
RC48 Combined With Chemotherapy in HER2-Positive Advanced Breast Cancer Patients With Prior TOP1i-ADC Failure
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Efficacy and Safety of Trastuzumab-rezetecan in HER2-Expressing Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
A Study to Assess the Efficiency of Trastuzumab Deruxtecan in Russian Breast Cancer Patients
- Status
- RECRUITING
- Phase
- NA
Evaluation of the Cardioprotective Effect of Nebivolol on Trastuzumab-Induced Cardiotoxicity in Breast Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Primary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With Herombopag
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Platform Trial Assessing Uptake, Safety and Efficacy of Theranostic Agents in Solid Tumors With Active Brain Metastases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Phase II Study to Assess the Efficacy of ASLAN001 Plus Capecitabine in CNS Metastases for HER2+ Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
T-DXd With or Without Neratinib for HER2 Positive Breast Cancer With Brain Metastasis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
HB1801 Combined Treatment of HER2-positive Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Tumor Markers for Efficacy of Dual-Target Therapy in HER2+ Breast Cancer
- Status
- COMPLETED
- Phase
- NA
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd
- Status
- RECRUITING
- Phase
- N/A
A Study of Surgery and Radiotherapy in People With Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study
- Status
- RECRUITING
- Phase
- N/A
Oral Metronomic Capecitabine Combined With Pyrotinib in ADC-treated HER2-positive Metastatic Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neratinib in Extended Adjuvant Treatment for HER2+ Early Breast Cancer With pCR But High-Risk Features: A Hebei Multi-Center Real-World Study
- Status
- NOT_YET_RECRUITING
- Phase
- N/A